Neurology® Podcast

Eligibility for Anti-Amyloid Treatment

23 min • 12 oktober 2023

Dr. Gregg Day talks with Dr. Vijay Ramanan about the clinical trial eligibility criteria for lecanemab treatment for participants with early Alzheimer disease and the generalizability of anti-amyloid treatment.

Read the related article in Neurology.

Visit NPub.org/Podcast for associated article links.

Senaste avsnitt

Podcastbild

00:00 -00:00
00:00 -00:00